Authors
Latest:
Using DOACs in People with Chronic Kidney Disease, with Kim Zuber, PA-C, and Jane Davis, DNPKim Zuber, PA-C, and Jane Davis, DNP, offer insight into the use of DOACs in people with atrial fibrillation and chronic kidney disease.
Latest:
Cardiometabolic Medicine: Seeing the Patient as a WholeThe panelists stress the significance of a comprehensive approach to patient care, acknowledging the interconnected nature of cardiovascular, kidney, endocrine, and obesity-related benefits, and highlighting that addressing secondary diseases can minimize overall disease risk in patients.
Latest:
Measuring Patient Satisfaction with Inflammatory Bowel Disease Treatments and Communication Regarding Treatment ChangesSilvio Danese, MD, PhD; Bruce Sands, MD, and Jean-Frederic Colombel, MD, conclude by sharing their approaches to evaluating patient satisfaction and expectations when providing care for ulcerative colitis and Crohn's disease, while also touching upon the importance of discussing the potential need for escalating or switching therapies to better manage the underlying disease processes.
Latest:
Don't Miss a Beat: Putting Evidence-Based Cardiometabolic Therapies into Practice, with Taher Modarressi, MDTaher Modarressi, MD, sits down with hosts to share tips and practical nuggets for cardiometabolic health specialists to optimize prescription and adherence to newer therapies.
Latest:
Practice Pearls for the Management of SCDA panel of experts in hematology discuss the future directions for sickle cell disease and share practice pearls for disease management.
Latest:
Addressing Vaccine Hesitancy and Uptake for SARS-CoV-2Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, and Madeline King, PharmD, BCIDP, provide insight on vaccine hesitancy among patients and the importance of increasing vaccine uptake to protect against SARS-CoV-2.
Latest:
Emerging Treatments of Anhedonia in Patients with Major Depressive DisorderDr Andrew Cutler and Dr Greg Mattingly comment about emerging treatments to treat anhedonia and highlight lifestyle modifications that support the wellbeing of patients with Major Depressive Disorder.
Latest:
Managing Patients With High-Risk PDR and DMEEhsan Rahimy, MD, outlines strategies for managing cases of high-risk PDR and DME, exploring new therapies and synergistic combinations with anti-VEGF and steroids for longer-lasting responses.
Latest:
Key Takeaways on the Optimal Management of Atopic DermatitisClosing out their discussion on the management of atopic dermatitis, expert panelists share clinical pearls and key takeaways from their discussion.
Latest:
Clinical Pearls for the Management of HSAn expert in dermatological conditions discusses office-based procedures that can benefit patients with HS and shares clinical pearls for the management of the disorder.
Latest:
New Topical Agents for Treatment of Plaque PsoriasisThis publication was developed independently by MJH Life Sciences Global Medical Affairs. Support for the thought leaders meeting and the publication was provided by Arcutis Biotherapeutics, Inc; The Bristol Myers Squibb Company; Janssen Global Services, LLC; and UCB, Inc.
Latest:
Systemic Lupus Erythematosus Treatment Advances: AnifrolumabThe rationale for using a newer monoclonal antibody therapy, anifrolumab, to manage patients with systemic lupus erythematosus.
Latest:
Final Thoughts on Retinal Disease Treatments and OutcomesExperts wrap up their discussion by highlighting key takeaways on the treatment of retinal diseases with anti-vascular endothelial growth factor (Anti-VEGF) therapies.
Latest:
Bridging the Gap for T1D ManagementExpert endocrinologists provide final thoughts on addressing unmet needs and improving the management of T1D.
Latest:
China Hits 1 Billion COVID-19 Vaccines AdministeredAfrica sees third wave as only 1% of the population is fully vaccinated.
Latest:
FDA Approves Fezolinetant for Moderate to Severe Hot Flashes in MenopauseAnnounced on May 12, 2023, the FDA's approval of fezolinetant (Veozah) marks their first approval for an NK3 receptor antagonist for the treatment of vasomotor symptoms of menopause.
Latest:
Future Directions for the Treatment of ASCVD and HypercholesterolemiaDrs Paul S. Jellinger, Erin D. Michos, Matthew J. Budoff, Christie Ballantyne, and Yehuda Handelsman share closing thoughts and advice for the management of ASCVD and hypercholesterolemia.
Latest:
Clinical Pearls on Lipid ManagementA panel of expert cardiologists share their clinical pearls for managing patients with hyperlipidemia.
Latest:
Clinical Pearls for the Treatment of Heart FailureDrs James Januzzi, Javed Butler, Robert Mentz, and Muthiah Vaduganathan share practice pearls for treating patients with heart failure, focusing on the future of treatment.
Latest:
What’s Next and Final Thoughts in SCDExperts look into what is next for sickle cell disease and provide key thoughts on the space.
Latest:
Systemic Treatments and Switching Therapy in Atopic DermatitisMedical experts evaluate the role of biologics in atopic dermatitis, including their efficacy and safety, and discuss reasons for switching between systemic treatments.
Latest:
Looking Into the Future of Lipid ManagementDr Taub, Dr Patel, and Dr Kohli look ahead to the future of the management of cardiovascular risk and hyperlipidemia
Latest:
Key Takeaways on FMTs in the Treatment of CDIExperts provide practice pearls for educating patients on and using FMTs for the management of CDI.
